实用临床医药杂志2024,Vol.28Issue(22) :143-148.DOI:10.7619/jcmp.20242229

射血分数保留型心力衰竭的诊疗进展

Progress in diagnosis and treatment of heart failure with preserved ejection fraction

潘怡婷 李岩松 丁胤彰 王凯 许迪
实用临床医药杂志2024,Vol.28Issue(22) :143-148.DOI:10.7619/jcmp.20242229

射血分数保留型心力衰竭的诊疗进展

Progress in diagnosis and treatment of heart failure with preserved ejection fraction

潘怡婷 1李岩松 1丁胤彰 1王凯 1许迪1
扫码查看

作者信息

  • 1. 南京医科大学第一附属医院老年心血管科,江苏南京,210029
  • 折叠

摘要

射血分数保留型心力衰竭(HFpEF)被定义为左心室射血分数(LVEF)≥50%,同时伴有钠尿肽(BNP)水平升高或其他充血证据.HFpEF有高发病率及高致死率的特点,现已超过射血分数减少型心力衰竭(HFrEF),成为心力衰竭的主流.本文对HFpEF的定义、流行病学、分类、诊断、病理、合并症及其治疗予以综述,旨在为临床研究提供证据.

Abstract

Heart failure with preserved ejection fraction(HFpEF)is defined as having a left ven-tricular ejection fraction(LVEF)of ≥50%accompanied by elevated natriuretic peptide(BNP)levels or other evidence of congestion.HFpEF is characterized by high morbidity and mortality rates and has surpassed heart failure with reduced ejection fraction(HFrEF)to become the predominant form of heart failure.This article reviewed the definition,epidemiology,classification,diagnosis,pathology,comorbidities,and treatment of HFpEF,providing evidence for clinical research.

关键词

射血分数保留型心力衰竭/射血分数减少型心力衰竭/心力衰竭/炎症/内皮功能障碍/舒张功能障碍

Key words

heart failure with preserved ejection fraction/heart failure with reduced ejection fraction/heart failure/inflammation/endothelial dysfunction/diastolic dysfunction

引用本文复制引用

出版年

2024
实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
段落导航相关论文